Target intelligence / Profile preview

Lipopolysaccharide transport protein complex B-F-G-C (LptBFGC) (LptBFGC)

Target
LptBFGC
Molecular classification
ABC transporter, Transporter, Membrane protein complex
01

Overview

The LptBFGC lipopolysaccharide transporter complex is a critical multi-protein assembly located in the inner membrane of Gram-negative bacteria (UniProt, 2024). It belongs to the ATP-binding cassette (ABC) transporter family and is responsible for the first step of moving lipopolysaccharide (LPS) molecules from the inner membrane across the periplasm to the outer membrane (Nature, 2019). The complex consists of the ATPase LptB, the transmembrane proteins LptF and LptG, and the bitopic membrane protein LptC (PubMed, 2020). By utilizing energy from ATP hydrolysis, the complex extracts LPS and pushes it onto a bridge formed by LptA, which eventually leads to the LptDE complex at the outer membrane (Science Advances, 2019). Because LPS is essential for the structural integrity and barrier function of the Gram-negative outer membrane, this complex is a high-priority target for the development of novel antibiotics (Journal of Biological Chemistry, 2021). Disrupting LptBFGC function leads to the accumulation of LPS in the inner membrane and eventual bacterial cell death (Nature Communications, 2018). Experimental drugs like thanatin have been shown to interact with components of this complex, particularly LptC, to inhibit bacterial growth (Science, 2019). This target is particularly relevant for treating multi-drug resistant Gram-negative pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii (Frontiers in Microbiology, 2022).

Other names
LptB2FGC complexInner membrane lipopolysaccharide transloconLptB-LptF-LptG-LptC complexLipopolysaccharide ABC transporter
02

Mechanism of action

Inhibition of the extraction of lipopolysaccharide (LPS) from the inner membrane and its subsequent transport to the outer membrane, disrupting the integrity of the bacterial cell envelope.

03

Biological functions

Lipopolysaccharide transportOuter membrane biogenesisLipid transport across the periplasm
04

Disease associations

Gram-negative bacterial infection
05

Safety considerations

Development of antimicrobial resistanceNarrow spectrum of activity (limited to Gram-negative bacteria)Potential for off-target effects in host microbiota
06

Interacting drugs

Thanatin
07

Biomarkers

LPS accumulation in the inner membraneOuter membrane permeability changesBacterial growth inhibition

Beyond the preview

Go deeper on Lipopolysaccharide transport protein complex B-F-G-C (LptBFGC) (LptBFGC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide transport protein complex B-F-G-C (LptBFGC) (LptBFGC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call